These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 18309965)
1. Safety of very tight blood glucose control in type 2 diabetes. Home P BMJ; 2008 Mar; 336(7642):458-9. PubMed ID: 18309965 [TBL] [Abstract][Full Text] [Related]
2. Safety of very tight glucose control in type 2 diabetes in question. Idris I Diabetes Obes Metab; 2008 May; 10(5):438. PubMed ID: 18431839 [No Abstract] [Full Text] [Related]
4. Strict glycaemic control in diabetic patients with CKD or ESRD: beneficial or deadly? Schernthaner G; Ritz E; Schernthaner GH Nephrol Dial Transplant; 2010 Jul; 25(7):2044-7. PubMed ID: 20388630 [No Abstract] [Full Text] [Related]
5. [New drugs for control of blood glucose in type 2 diabetes: summary of the NICE guidelines]. Adler AI; Shaw EJ; Stokes T; Ruiz F Praxis (Bern 1994); 2009 Oct; 98(20):1161-3. PubMed ID: 19809980 [No Abstract] [Full Text] [Related]
7. The efficacy and safety of glimepiride in the management of type 2 diabetes in Muslim patients during Ramadan. Glimepiride in Ramadan (GLIRA) Study Group Diabetes Care; 2005 Feb; 28(2):421-2. PubMed ID: 15677804 [No Abstract] [Full Text] [Related]
8. Intensified glucose control in type 2 diabetes--whose agenda? Yudkin JS; Richter B; Gale EA Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903 [No Abstract] [Full Text] [Related]
13. Glucoregulation in type 2 diabetes: the lower the better? Glycosylated HbA1c of 6.5% seems to be the limit. Jazet IM; Meinders AE Eur J Intern Med; 2009 May; 20(3):232-5. PubMed ID: 19393489 [No Abstract] [Full Text] [Related]
14. Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment. Rodriguez-Gutierrez R; Lipska KJ; McCoy RG JAMA Intern Med; 2016 Mar; 176(3):300-1. PubMed ID: 26882223 [No Abstract] [Full Text] [Related]
15. [Insulin therapy in patients with type 2 diabetes]. Siegmund T; Schumm-Draeger PM MMW Fortschr Med; 2008 May; 150(18):32-5; quiz 36. PubMed ID: 18533606 [No Abstract] [Full Text] [Related]
17. Case study 1: exploring the pharmacologic agents for treatment of type 2 diabetes. Martin CL Diabetes Educ; 2007; 33 Suppl 1():6S-13S. PubMed ID: 17272803 [No Abstract] [Full Text] [Related]
18. [Control of diabetes mellitus]. Daweke H Verh Dtsch Ges Inn Med; 1990; 96():175-82. PubMed ID: 2092437 [No Abstract] [Full Text] [Related]
19. [Oral antidiabetics: how you take the right choice]. Siegmund T; Schumm-Draeger PM MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():46-51; quiz 52. PubMed ID: 22916425 [No Abstract] [Full Text] [Related]
20. Non-alcoholic fatty liver disease and type 2 diabetes: Importance of glycemic control. Bloomgarden Z J Diabetes; 2017 Aug; 9(8):722-723. PubMed ID: 28513098 [No Abstract] [Full Text] [Related] [Next] [New Search]